High prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease receiving anti-tumor necrosis factor therapy.
Autor: | Likhitsup, Alisa1,2 alikhitsup@gmail.com, Dundulis, Jason1,2, Ansari, Shaya1,2, Patibandla, Sruthi1, Hutton, Colleen3, Kennedy, Kevin3, Helzberg, John H.1,2, Chhabra, Rajiv1,2 |
---|---|
Zdroj: | Annals of Gastroenterology. 2019, Vol. 32 Issue 5, p463-468. 7p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |